Portfolio company
Cernostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops image analysis tests for tissue biopsies to predict cancer risk in patients with Barrett's esophagus for gastroenterologists and clinicians.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Advanced computer-aided gastrointestinal diagnosis
This company develops artificial intelligence software for upper gastrointestinal endoscopy to assist endoscopists in procedural monitoring and landmark visualization.
Magentiq Eye
This company develops artificial intelligence software for gastroenterology clinics to assist clinicians with polyp detection and analysis during colonoscopy procedures.
Digistain
This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.
Docbot
This company develops artificial intelligence software for real-time image analysis and automated reporting during gastrointestinal endoscopy procedures for healthcare providers and physicians.
Iterative Scopes
This company develops artificial intelligence software for gastroenterology to assist clinicians with polyp detection and clinical trial recruitment.
Glycanostics
This digital health company develops non-invasive liquid biopsy tests for early-stage cancer detection, serving clinical laboratories, hospitals and oncology professionals.
Cleveland Diagnostics
This company develops blood-based protein biomarker tests for early cancer detection to help clinicians and laboratories identify high-risk patients and reduce unnecessary biopsies.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
